10 Results

People

  1. Scher
    Scher
  2. Cordon-Cardo
    Cordon-Cardo
  3. Tong
    Tong
  4. Larson
    Larson
  5. Slovin
    Slovin
  6. Drobnjak
    Drobnjak
  7. Imbriaco
    Imbriaco
  8. Kelly
    Kelly
  9. Moore
    Moore
  10. Reuter
    Reuter

Groups

  1. Department of Medicine (10)
  2. Genitourinary Oncology Service (10)
  3. Sloan Kettering Institute Faculty (10)
  4. Solid Tumor Oncology Division (10)
  5. GSK Faculty (9)
  6. Molecular Pharmacology and Chemistry Program Faculty (7)
  7. Molecular Imaging and Therapy Service (4)
  8. Radiology, Department of (4)
  9. Breast Medicine Service (3)
  10. Hematologic Malignancies, Division of (3)
  1. "Sloan Kettering Institute Faculty"
  2. "priority journal"
  3. "Howard Scher"
  4. "Clinical Cancer Research"
Formats
  1. Journal Article (10)
Groups
  1. Department of Medicine (10)
  2. Genitourinary Oncology Service (10)
  3. Sloan Kettering Institute Faculty (10)
  4. Solid Tumor Oncology Division (10)
  5. GSK Faculty (9)
  6. Molecular Pharmacology and Chemistry Program Faculty (7)

More Groups

People
  1. Howard Scher (10)
  2. Carlos Cordon-Cardo (4)
  3. Steven Larson (4)
  4. William Tong (4)
  5. Susan Slovin (3)
  6. Victor Reuter (3)

More People

Years
  1. 2003 (1)
  2. 2002 (2)
  3. 2000 (1)
  4. 1999 (1)
  5. 1998 (2)
  6. 1997 (2)

More Years

Publications
  1. Clinical Cancer Research (10)
Publishers
  1. American Association for Cancer Research (10)

Results (10)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Dose escalation study of intravenous estramustine phosphate in combination with paclitaxel and carboplatin in patients with advanced prostate cancer
    Journal Article

    Kelly, W. K.; Zhu, A. X.; Scher, H.; Curley, T.; Fallon, M.; Slovin, S.; Schwartz, L.; Larson, S.; Tong, W.; Hartley-Asp, B.; more...
    Clinical Cancer Research (2003)

    Fulltext@MSK | Save
  • 17-Allylamino-17-demethoxygeldanamycin induces the degradation of androgen receptor and HER-2/neu and inhibits the growth of prostate cancer xenografts
    Journal Article

    Solit, D. B.; Zheng, F. F.; Drobnjak, M.; Münster, P. N.; Higgins, B.; Verbel, D.; Heller, G.; Tong, W.; Cordon-Cardo, C.; Agus, D. B.; more...
    Clinical Cancer Research (2002)

    Fulltext@MSK | Save
  • Phase I trial of BCL-2 antisense oligonucleotide (G3139) administered by continuous intravenous infusion in patients with advanced cancer
    Journal Article

    Morris, M. J.; Tong, W. P.; Cordon-Cardo, C.; Drobnjak, M.; Kelly, W. K.; Slovin, S. F.; Terry, K. L.; Siedlecki, K.; Swanson, P.; Rafi, M.; more...
    Clinical Cancer Research (2002)

    Fulltext@MSK | Save
  • Co-administration of probenecid, an inhibitor of a cMOAT/MRP-like plasma membrane ATPase, greatly enhanced the efficacy of a new 10-deazaaminopterin against human solid tumors in vivo
    Journal Article

    Sirotnak, F. M.; Wendel, H. G.; Bornmann, W. G. B.; Tong, W. P.; Miller, V. A.; Scher, H. I.; Kris, M. G.
    Clinical Cancer Research (2000)

    Fulltext@MSK | Save
  • Rhenium-186-labeled hydroxyethylidene diphosphonate dosimetry and dosing guidelines for the palliation of skeletal metastases from androgen-independent prostate cancer
    Journal Article

    Graham, M. C.; Scher, H. I.; Liu, G. B.; Yeh, S. D. J.; Curley, T.; Daghighian, F.; Goldsmith, S. J.; Larson, S. M.
    Clinical Cancer Research (1999)

    Fulltext@MSK | Save
  • A new parameter for measuring metastatic bone involvement by prostate cancer: The Bone Scan Index
    Journal Article

    Imbriaco, M.; Larson, S. M.; Yeung, H. W.; Mawlawi, O. R.; Erdi, Y.; Venkatraman, E. S.; Scher, H. I.
    Clinical Cancer Research (1998)

    Fulltext@MSK | Save
  • Interferon-γ and monoclonal antibody (131)I-labeled CC49: Outcomes in patients with androgen-independent prostate cancer
    Journal Article

    Slovin, S. F.; Scher, H. I.; Divgi, C. R.; Reuter, V.; Sgouros, G.; Moore, M.; Weingard, K.; Pettengall, R.; Imbriaco, M.; El-Shirbiny, A.; more...
    Clinical Cancer Research (1998)

    Fulltext@MSK | Save
  • Expression of cyclin D1, but not cyclins E and A, is related to progression in bilharzial bladder cancer
    Journal Article

    Osman, I.; Scher, H.; Zhang, Z. F.; Soos, T. J.; Hamza, R.; Eissa, S.; Khaled, H.; Koff, A.; Cordon-Cardo, C.
    Clinical Cancer Research (1997)

    Fulltext@MSK | Save
  • Relative contribution of normal and neoplastic cells determines telomerase activity and telomere length in primary cancers of the prostate, colon, and sarcoma
    Journal Article

    Engelhardt, M.; Albanell, J.; Drullinsky, P.; Han, W.; Guillem, J.; Scher, H. I.; Reuter, V.; Moore, M. A. S.
    Clinical Cancer Research (1997)

    Fulltext@MSK | Save
  • Changing pattern of expression of the epidermal growth factor receptor and transforming growth factor α in the progression of prostatic neoplasms
    Journal Article

    Scher, H. I.; Sarkis, A.; Reuter, V.; Cohen, D.; Netto, G.; Petrylak, D.; Lianes, P.; Fuks, Z.; Mendelsohn, J.; Cordon-Cardo, C.
    Clinical Cancer Research (1995)

    Fulltext@MSK | Save